IGIP19162, Hezel, D-US-60010-001, Pancreas, Irinotecan Liposomal Injection
Basic Study Information
Purpose:
The purpose of this study is to look at the efficacy and safety of Irinotecan liposome
injection in combination with other approved drugs used for cancer therapy, namely
5 fluorouracil/leucovorin (5FU/LV) plus oxaliplatin compared to nab-paclitaxel + gemcitabine
treatment in improving the overall survival of patients not previously treated for
metastatic pancreatic cancer.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Aram Hezel
Study Contact Information
Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search